New study aims to predict severe kidney injury before it happens
NCT ID NCT05988658
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This study is testing whether adding blood and urine biomarkers to a computer risk score can better predict which hospitalized patients will develop severe acute kidney injury (AKI). Researchers will enroll 800 adults at high risk (top 10% by the risk score) and track them for three days. The goal is to improve early detection, not to test a treatment.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a more accurate way to predict severe kidney injury in hospitalized patients, allowing earlier intervention.
- What could go wrong
- This is an observational study, not a treatment trial. The risk score and biomarkers are being tested for prediction only, and may not improve patient outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Chicago Medical Center
RECRUITINGChicago, Illinois, 60637, United States
-
University of Wisconsin Hospital
RECRUITINGMadison, Wisconsin, 53792, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which emergency dialysis saves more lives? a new study investigates
- Could your heart hold the key to Alzheimer's prevention?
- A simple sensor on the back could warn of kidney danger during heart surgery
- Can a common blood thinner be safe for ICU patients with liver issues?
- A urine test that could foresee kidney danger in the ICU
- Which citrate solution minimizes metabolic chaos in kidney therapy?